MDWD
Mediwound Ltd.
A biopharmaceutical company that makes NexoBrid, a pineapple-enzyme gel that dissolves dead tissue from severe burn wounds without surgery. Founded in 2000 as a spinoff from Hebrew University of Jerusalem research into bromelain, the enzyme found in pineapple stems. The company's name plays on "medi" (medical) and "wound," reflecting its focus on wound care.
CINS: M68830104HealthcareIL1 holder
Dec 20, 2022 — Reclassified as MediWound Ltd (0.142857 shares per share)
Total Value
$4.0K
Total Shares
2.0K
Net Share Change
-832.1K
Activity
1 selling
Investor
Value
Shares
Weight
Change
